Cervical cancer is a cancer of the female genital organs that occurs in the cervix, which is the entrance to the uterus, and is caused by human papillomavirus, human immunodeficiency virus, and herpes virus. Cervical cancer goes through a precancerous stage for a considerable period of time before becoming cancerous. If not detected and treated in the precancerous stage, it progresses to invasive cervical cancer, so it is important to screen for early detection and treatment.
Cervical cancer is a cancer of the female genital organs that occurs in the cervix, which is the entrance to the uterus, and is caused by human papillomavirus, human immunodeficiency virus, and herpes virus. Cervical cancer goes through a precancerous stage for a considerable period of time before becoming cancerous. If not detected and treated in the precancerous stage, it progresses to invasive cervical cancer, so it is important to screen for early detection and treatment.
In particular, more than 600,000 people worldwide have been diagnosed with cervical cancer, and in Korea alone, 3,273 cases of cervical cancer, excluding intraepithelial cancer, occurred as of 2021. The number of deaths through definite diagnosis is 310,000 worldwide, with a mortality rate of more than 50%. In particular, 80% of deaths occur in developing countries or third world countries with low screening rates. As it is important to screen for cervical cancer in advance, it is necessary to have a screening device that can be used even in countries without medical infrastructure. AIDOT Co., Ltd. is a company that developed ‘Cerviray AI’, which is optimized for areas with poor medical infrastructure and can screen for cervical cancer. So we covered Aidot Co., Ltd., which broke down barriers such as costs, facilities, and manpower by grafting AI into the medical field.
In particular, more than 600,000 people worldwide have been diagnosed with cervical cancer, and in Korea alone, 3,273 cases of cervical cancer, excluding intraepithelial cancer, occurred as of 2021. The number of deaths through definite diagnosis is 310,000 worldwide, with a mortality rate of more than 50%. In particular, 80% of deaths occur in developing countries or third world countries with low screening rates. As it is important to screen for cervical cancer in advance, it is necessary to have a screening device that can be used even in countries without medical infrastructure. AIDOT Co., Ltd. is a company that developed ‘Cerviray AI’, which is optimized for areas with poor medical infrastructure and can screen for cervical cancer. So we covered Aidot Co., Ltd., which broke down barriers such as costs, facilities, and manpower by grafting AI into the medical field.
Comments
There are no comments to display.
Comments can be added by Member only.